RSS feed

Publications by Torgeir Wethal

22 publications found

Original articles

Sandvig HV, Aam S, Alme KN, Lydersen S, Magne Ueland P, Ulvik A, Wethal T, Saltvedt I, Knapskog AB (2024)
Neopterin, kynurenine metabolites, and indexes related to vitamin B6 are associated with post-stroke cognitive impairment: The Nor-COAST study
Brain Behav Immun, 118, 167-177
DOI 10.1016/j.bbi.2024.02.030, PubMed 38428649

Phan A, Askim T, Lydersen S, Indredavik B, Wethal T (2023)
Accelerometer-measured physical activity at 3 months as a predictor of symptoms of depression and anxiety 1 year after stroke: a multicentre prospective cohort study in central Norway
J Rehabil Med, 55, jrm12309
DOI 10.2340/jrm.v55.12309, PubMed 37970656

Sandvig HV, Aam S, Alme KN, Askim T, Beyer MK, Ellekjær H, Ihle-Hansen H, Lydersen S, Mollnes TE, Munthe-Kaas R, Næss H, Saltvedt I, Seljeseth YM, Thingstad P, Wethal T, Knapskog AB (2023)
Plasma Inflammatory Biomarkers Are Associated With Poststroke Cognitive Impairment: The Nor-COAST Study
Stroke, 54 (5), 1303-1311
DOI 10.1161/STROKEAHA.122.041965, PubMed 37026459

Giskeødegård GF, Madssen TS, Sangermani M, Lundgren S, Wethal T, Andreassen T, Reidunsdatter RJ, Bathen TF (2022)
Longitudinal Changes in Circulating Metabolites and Lipoproteins After Breast Cancer Treatment
Front Oncol, 12, 919522
DOI 10.3389/fonc.2022.919522, PubMed 35785197

Mecinaj A, Gulati G, Heck SL, Holte E, Fagerland MW, Larsen AI, Blix ES, Geisler J, Wethal T, Omland T (2021)
Rationale and design of the PRevention of cArdiac Dysfunction during Adjuvant breast cancer therapy (PRADA II) trial: a randomized, placebo-controlled, multicenter trial
Cardiooncology, 7 (1), 33
DOI 10.1186/s40959-021-00115-w, PubMed 34579775

Gynnild MN, Hageman SHJ, Dorresteijn JAN, Spigset O, Lydersen S, Wethal T, Saltvedt I, Visseren FLJ, Ellekjær H (2021)
Risk Stratification in Patients with Ischemic Stroke and Residual Cardiovascular Risk with Current Secondary Prevention
Clin Epidemiol, 13, 813-823
DOI 10.2147/CLEP.S322779, PubMed 34566434

Ildstad F, Ellekjær H, Wethal T, Lydersen S, Fjærtoft H, Indredavik B (2021)
ABCD3-I and ABCD2 Scores in a TIA Population with Low Stroke Risk
Stroke Res Treat, 2021, 8845898
DOI 10.1155/2021/8845898, PubMed 33708373

Ildstad F, Ellekjær H, Wethal T, Lydersen S, Sund JK, Fjærtoft H, Schüler S, Horn JW, Bråthen G, Midtsæther AG, Morsund ÅH, Lillebø ML, Seljeseth YM, Indredavik B (2019)
Stroke risk after transient ischemic attack in a Norwegian prospective cohort
BMC Neurol, 19 (1), 2
DOI 10.1186/s12883-018-1225-y, PubMed 30606138

Stenehjem JS, Smeland KB, Murbraech K, Holte H, Kvaløy SO, Wethal T, Kiserud CE, Samersaw-Lund MB (2017)
Obstructive and restrictive pulmonary dysfunction in long-term lymphoma survivors after high-dose therapy with autologous stem cell transplantation
Acta Oncol, 57 (6), 773-781
DOI 10.1080/0284186X.2017.1406137, PubMed 29171324

Murbraech K, Wethal T, Smeland KB, Holte H, Loge JH, Holte E, Rösner A, Dalen H, Kiserud CE, Aakhus S (2016)
Valvular Dysfunction in Lymphoma Survivors Treated With Autologous Stem Cell Transplantation: A National Cross-Sectional Study
JACC Cardiovasc Imaging, 9 (3), 230-9
DOI 10.1016/j.jcmg.2015.06.028, PubMed 26897666

Varmdal T, Bakken IJ, Janszky I, Wethal T, Ellekjær H, Rohweder G, Fjærtoft H, Ebbing M, Bønaa KH (2015)
Comparison of the validity of stroke diagnoses in a medical quality register and an administrative health register
Scand J Public Health, 44 (2), 143-9
DOI 10.1177/1403494815621641, PubMed 26660300

Murbraech K, Smeland KB, Holte H, Loge JH, Lund MB, Wethal T, Holte E, Rösner A, Dalen H, Kvaløy S, Falk RS, Aakhus S, Kiserud CE (2015)
Heart Failure and Asymptomatic Left Ventricular Systolic Dysfunction in Lymphoma Survivors Treated With Autologous Stem-Cell Transplantation: A National Cross-Sectional Study
J Clin Oncol, 33 (24), 2683-91
DOI 10.1200/JCO.2015.60.8125, PubMed 26169610

Wethal T, Røysland R, Torbjørn O, Kjekshus J (2015)
Exercise-induced vasodilation in healthy males: A marker of reduced endothelial function
Scand Cardiovasc J, 49 (3), 123-9
DOI 10.3109/14017431.2015.1021708, PubMed 25752356

Wethal T, Nedregaard B, Andersen R, Fosså A, Lund MB, Günther A, Kvaløy S, Fosså SD, Kjekshus J (2013)
Atherosclerotic lesions in lymphoma survivors treated with radiotherapy
Radiother Oncol, 110 (3), 448-54
DOI 10.1016/j.radonc.2013.10.029, PubMed 24231235

Tsai HR, Gjesdal O, Wethal T, Haugaa KH, Fosså A, Fosså SD, Edvardsen T (2011)
Left ventricular function assessed by two-dimensional speckle tracking echocardiography in long-term survivors of Hodgkin's lymphoma treated by mediastinal radiotherapy with or without anthracycline therapy
Am J Cardiol, 107 (3), 472-7
DOI 10.1016/j.amjcard.2010.09.048, PubMed 21257017

Haugnes HS, Wethal T, Aass N, Dahl O, Klepp O, Langberg CW, Wilsgaard T, Bremnes RM, Fosså SD (2010)
Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study
J Clin Oncol, 28 (30), 4649-57
DOI 10.1200/JCO.2010.29.9362, PubMed 20855830

Wethal T, Haugnes HS, Kjekshus J, Småstuen MC, Ueland T, Aukrust P, Fosså SD (2010)
C-reactive protein; a potential marker of second cancer and cardiovascular disease in testicular cancer survivors?
Eur J Cancer, 46 (18), 3425-33
DOI 10.1016/j.ejca.2010.08.004, PubMed 20832295

Andersen R, Wethal T, Günther A, Fosså A, Edvardsen T, Fosså SD, Kjekshus J (2009)
Relation of coronary artery calcium score to premature coronary artery disease in survivors >15 years of Hodgkin's lymphoma
Am J Cardiol, 105 (2), 149-52
DOI 10.1016/j.amjcard.2009.09.005, PubMed 20102909

Wethal T, Lund MB, Edvardsen T, Fosså SD, Pripp AH, Holte H, Kjekshus J, Fosså A (2009)
Valvular dysfunction and left ventricular changes in Hodgkin's lymphoma survivors. A longitudinal study
Br J Cancer, 101 (4), 575-81
DOI 10.1038/sj.bjc.6605191, PubMed 19623176

Wethal T, Kjekshus J, Røislien J, Ueland T, Andreassen AK, Wergeland R, Aukrust P, Fosså SD (2007)
Treatment-related differences in cardiovascular risk factors in long-term survivors of testicular cancer
J Cancer Surviv, 1 (1), 8-16
DOI 10.1007/s11764-007-0012-3, PubMed 18648940

Other articles

Stenehjem JS, Smeland KB, Murbraech K, Holte H, Kvaløy S, Wethal T, Kiserud CE, Lund MB (2016)
Diffusing capacity impairment is prevalent in long-term lymphoma survivors after high-dose therapy with autologous stem cell transplantation
Bone Marrow Transplant, 52 (4), 646-649
DOI 10.1038/bmt.2016.338, PubMed 27991891

Theses

Wethal T (2010)
Life-threatening long-term treatment-related adverse effects in testicular cancer and Hodgkin's lymphoma survivors with emphasis on cardiovascular disease
In Series of dissertations submitted to the Faculty of Medicine, University of Oslo, Unipub, Oslo, no. 993, 1 b. (flere pag.)
BIBSYS 102146527, ISBN 978-82-8072-519-6